Philadelphia, PA, June 4, 2025 - NodThera, a leading clinical-stage biotech delivering a paradigm shift in the treatment of chronic inflammatory diseases through selective modulation of the NLRP3 ...
Important Milestone for European Phase III Trial Triggers 9-Month Follow-Up Period. Data Readout Expected in the Middle of 2016 MONT-SAINT-GUIBERT, Belgium, Celyad SA (Euronext Brussels, Euronext ...
Phase two of Venture Global’s Plaquemines liquefied natural gas export facility in the US state of Louisiana has taken a significant step forward, with the announcement that Chart Industries has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback